Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLTFF- In good standing to challenge Merck’s Keytruda.

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Jan 17, 2022 11:57am

1086 Views

Post# 34324683

RE:RE:RE:RE:RE:TLTFF- In good standing to challenge Merck’s Keytruda.

Goosey, "severe side effects" might be an understatement. My next door neighbor was a tough 6' 5'' and 250 lbs. After Keytruda treatments he would sit on his sofa and cry. He lasted 4 or 5 months. RIP, Rich.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?